Kingdon Capital Management, L.L.C. Regeneron Pharmaceuticals, Inc. Transaction History

Kingdon Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $639,078 - $939,911	-1,901 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $16.6 Million - $22.8 Million	-60,564 Reduced 96.96%	1,901 $714,000
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $5.91 Million - $6.88 Million	21,594 Added 52.83%	62,465 $17.3 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $12.2 Million - $17 Million	40,871 New	40,871 $12.8 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.